Short Interest in Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Expands By 111.0%

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) saw a large growth in short interest in the month of March. As of March 13th, there was short interest totaling 1,841,462 shares, a growth of 111.0% from the February 26th total of 872,774 shares. Currently, 2.9% of the shares of the company are sold short. Based on an average daily volume of 2,110,901 shares, the days-to-cover ratio is currently 0.9 days.

Hedge Funds Weigh In On Bioceres Crop Solutions

Large investors have recently added to or reduced their stakes in the stock. Bank of America Corp DE grew its position in Bioceres Crop Solutions by 186.8% in the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock valued at $35,000 after acquiring an additional 3,735 shares in the last quarter. Jones Financial Companies Lllp raised its holdings in shares of Bioceres Crop Solutions by 3,535.8% in the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock valued at $25,000 after buying an additional 5,339 shares during the last quarter. Ardsley Advisory Partners LP increased its stake in Bioceres Crop Solutions by 4.7% in the 2nd quarter. Ardsley Advisory Partners LP now owns 993,614 shares of the company’s stock valued at $4,441,000 after buying an additional 45,000 shares during the period. Jane Street Group LLC purchased a new position in shares of Bioceres Crop Solutions during the 2nd quarter worth approximately $202,000. Finally, PDT Partners LLC grew its stake in shares of Bioceres Crop Solutions by 58.9% during the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock worth $126,000 after purchasing an additional 10,449 shares during the period. 17.68% of the stock is currently owned by institutional investors and hedge funds.

Bioceres Crop Solutions Stock Performance

Shares of BIOX traded down $0.02 during trading hours on Friday, hitting $0.40. The stock had a trading volume of 136,985 shares, compared to its average volume of 961,486. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.90 and a quick ratio of 0.69. The firm has a market capitalization of $25.29 million, a PE ratio of -0.11 and a beta of 0.53. The stock has a fifty day moving average price of $0.67 and a 200 day moving average price of $1.28. Bioceres Crop Solutions has a 12 month low of $0.35 and a 12 month high of $5.18.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings data on Friday, March 13th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.15). Bioceres Crop Solutions had a negative return on equity of 22.43% and a negative net margin of 82.83%.The firm had revenue of $73.67 million during the quarter, compared to the consensus estimate of $104.55 million. Analysts anticipate that Bioceres Crop Solutions will post -0.05 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on BIOX. Canaccord Genuity Group decreased their target price on Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating on the stock in a research note on Friday, January 2nd. Weiss Ratings restated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a report on Monday, December 29th. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Bioceres Crop Solutions has a consensus rating of “Hold” and an average price target of $4.00.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.